Integrating network pharmacology and transcriptomics to study the potential mechanism of Jingzhi Niuhuang Jiedu tablet in rats with accumulation of heat in the lungs and stomach.

Autor: Dai ZQ; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Guo ZQ; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Zhang T; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Chu YF; Beijing Tongrentang Science and Technology Development Co. Technology Development Co., Ltd., Beijing, 100079, China., Yan Y; Beijing Tongrentang Science and Technology Development Co. Technology Development Co., Ltd., Beijing, 100079, China., Gao F; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Li SL; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Gu YH; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Jiao JY; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Lin YX; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China., Zhao SW; Beijing Tongrentang Science and Technology Development Co. Technology Development Co., Ltd., Beijing, 100079, China. Electronic address: zhaoshuwu@tongrentangkj.com., Xu B; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China. Electronic address: weichenxubing@126.com., Lei HM; School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, China. Electronic address: hm_lei@126.com.
Jazyk: angličtina
Zdroj: Journal of ethnopharmacology [J Ethnopharmacol] 2025 Jan 30; Vol. 337 (Pt 2), pp. 118890. Date of Electronic Publication: 2024 Oct 02.
DOI: 10.1016/j.jep.2024.118890
Abstrakt: Ethnopharmacological Relevance: Accumulation of heat in the lungs and stomach (AHLS) is an important syndrome within the realm of traditional Chinese medicine (TCM). It is the fundamental reason behind numerous illnesses, including mouth ulcers, dermatological conditions, acne, and pharyngitis. Jingzhi Niuhuang Jiedu tablet (JN) serves as the representative prescription for treatment of AHLS clinically. However, the effective components and mechanism of JN's impact on AHLS remain unexplored.
Aim of the Study: The objective of this research was to analyze the effective components of JN and investigate the therapeutic effect and potential mechanism of JN on AHLS.
Materials and Methods: The effective compounds of JN extract were analyzed and identified using UHPLC-Q-Exactive/HRMS. Utilizing network pharmacology to investigate JN's multi-target, multi-pathway process in treating AHLS. Subsequently, anti-inflammatory activities of JN extract were evaluated in the RAW264.7 cells stimulated by lipopolysaccharide (LPS). In addition, a rat AHLS model induced by LPS and dried ginger was established. Pathological changes in rat lung and stomach tissues observed by HE staining and Masson's trichrome staining. Additionally, the expression of TNF-α, IL-6, and IL-1β in bronchoalveolar lavage fluid (BALF) was identified through the ELISA assay. For a deeper understanding of how JN might affect AHLS, transcriptomics was utilized to examine differential genes and their underlying mechanisms. Concurrently, techniques like quantitative polymerase chain reaction (q-PCR), immunofluorescence, and western blotting (WB) were employed to confirm various mRNA and protein expression, including Il17ra, Il17re, IL-17A, IL-1β, IL-6, PPARγ, PGC1-α and UCP1.
Results: We identified 178 potential effective components in the JN extract. Network pharmacology analysis showed that the 144 components in JN act on 200 key targets for the treatment of AHLS by suppressing inflammation, regulating energy metabolism, and gastric function. In addition, JN suppressed the LPS-stimulated generation of NO, TNF-α, IL-1β, and IL-6 in RAW264.7 cells. And JN treatment effectively alleviated lung and stomach injury and reduced inflammation in rats. Analysis of RNA-seq from lung tissues revealed JN's substantial control over crucial genes in the IL-17 signaling pathway, including Il1b and Il17ra. Likewise, RNA sequencing of stomach tissues revealed that JN markedly decreased crucial genes in the Thermogenesis pathway, including Ppargc1a and Ppara. Additional experimental findings confirmed that treatment with JN significantly reduced the expression levels of mRNA (Il17ra, Il17re, Il1b, Ppargc1a and Ucp1), and the expression levels of protein (IL-17A, IL-1β, IL-6, PPARγ, PGC1-α and UCP1).
Conclusion: This study not only analyzes the effective components of JN but also reveals that JN could effectively ameliorate AHLS by inhibiting IL-17 signaling pathway and Thermogenesis pathway, which provides evidence for subsequent clinical studies and drug development.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE